Skyepharma

Skyepharma is a drug delivery company developing oral and inhalation products. Its proprietary drug delivery technologies enable the development of new formulations of existing products as well as new chemical entities to provide a clinical benefit to patients. The company develops Geomatrix and Geoclock technologies that enable controlled- or timed-release versions of immediate-release products to be developed providing advantages to both partner companies and patients. 
TypeSubsidiary
Parent CompanyVectura Group
HQSaint-Quentin-Fallavier, FR
Founded1996
Websiteskyepharma.fr
Cybersecurity ratingAMore
Skyepharma was founded in 1996 and is headquartered in Saint-Quentin-Fallavier, FR

Viewing summary data as a guest

Sign up for free to see all data

Skyepharma Office Locations

Skyepharma has an office in Saint-Quentin-Fallavier
Saint-Quentin-Fallavier, FR (HQ)
55 Rue du Montmurier
Show all (1)

Skyepharma Financials and Metrics

Summary Metrics

Founding Date

1996
Skyepharma is a subsidiary of Vectura Group

Skyepharma Revenue

Skyepharma's revenue was reported to be £95.9 m in FY, 2015 which is a 29.9% increase from the previous period.
GBPFY, 2013FY, 2014FY, 2015

Revenue

62.6m73.8m95.9m

Revenue growth, %

18%30%

Cost of goods sold

33.2m32.9m43.1m

Gross profit

29.4m40.9m52.8m
Show all financial metrics

Skyepharma Cybersecurity Score

Cybersecurity ratingPremium dataset

A

92/100

SecurityScorecard logo

Skyepharma Online and Social Media Presence

Embed Graph

Skyepharma News and Updates

Oral Drug Delivery 2018 Global Market Key Players - Encap, Skyepharma, Aegis Therapeutics, Aptalis, Flamel Technologies, Alkermes, Ethypharm, Emisphere Technologies......

Oral Drug Delivery – Global Market Growth, Opportunities, Analysis Of Top Key Players And Forecast To 2023 Posted via Industry Today. Follow us on Twitter @IndustryToday

Skyepharma Blogs

Skyepharma : Expert CDMO in the Compression of Complex Tablets

L’article Skyepharma : Expert CDMO in the Compression of Complex Tablets est apparu en premier sur Skyepharma.

Newly Independent CDMO Skyepharma Looks to Expansion

L’article Newly Independent CDMO Skyepharma Looks to Expansion est apparu en premier sur Skyepharma.

UHPLC : The analytical answer to current needs

L’article UHPLC : The analytical answer to current needs est apparu en premier sur Skyepharma.

Coating your oral solid drugs protect & optimize! Mastering the coating process

L’article Coating your oral solid drugs protect & optimize! Mastering the coating process est apparu en premier sur Skyepharma.

Press-coated tablets: Increase knowledge through research

L’article Press-coated tablets: Increase knowledge through research est apparu en premier sur Skyepharma.

Bioavailability is a matter of size!

L’article Bioavailability is a matter of size! est apparu en premier sur Skyepharma.
Show more

Skyepharma Frequently Asked Questions

  • When was Skyepharma founded?

    Skyepharma was founded in 1996.

  • How many employees does Skyepharma have?

    Skyepharma has 183 employees.

  • What is Skyepharma revenue?

    Latest Skyepharma annual revenue is £95.9 m.

  • What is Skyepharma revenue per employee?

    Latest Skyepharma revenue per employee is £524 k.

  • Who are Skyepharma competitors?

    Competitors of Skyepharma include CRBio, Paion and Antidote.

  • Where is Skyepharma headquarters?

    Skyepharma headquarters is located at 55 Rue du Montmurier, Saint-Quentin-Fallavier.

  • Where are Skyepharma offices?

    Skyepharma has an office in Saint-Quentin-Fallavier.

  • How many offices does Skyepharma have?

    Skyepharma has 1 office.